Point72 Hong Kong Ltd Invests $8.15 Million in The Clorox Company (NYSE:CLX)

Point72 Hong Kong Ltd purchased a new stake in The Clorox Company (NYSE:CLX - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 50,010 shares of the company's stock, valued at approximately $8,147,000.

A number of other hedge funds have also recently made changes to their positions in CLX. White Knight Strategic Wealth Advisors LLC lifted its holdings in Clorox by 19.6% during the 3rd quarter. White Knight Strategic Wealth Advisors LLC now owns 2,608 shares of the company's stock worth $425,000 after buying an additional 427 shares during the period. Public Sector Pension Investment Board lifted its stake in shares of Clorox by 12.6% in the third quarter. Public Sector Pension Investment Board now owns 5,375 shares of the company's stock worth $876,000 after acquiring an additional 600 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Clorox by 2.6% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 49,468 shares of the company's stock worth $8,059,000 after acquiring an additional 1,247 shares during the period. CreativeOne Wealth LLC bought a new stake in Clorox in the third quarter valued at approximately $213,000. Finally, Townsquare Capital LLC acquired a new stake in Clorox during the 3rd quarter valued at approximately $363,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. This trade represents a 11.40 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.57% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the stock. Barclays upped their price objective on shares of Clorox from $137.00 to $139.00 and gave the company an "underweight" rating in a research note on Friday, November 1st. BNP Paribas upgraded Clorox to a "strong sell" rating in a report on Friday, September 6th. TD Cowen raised Clorox from a "sell" rating to a "hold" rating and boosted their price objective for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Evercore ISI dropped their price target on Clorox from $140.00 to $139.00 and set an "underperform" rating on the stock in a research note on Monday, October 14th. Finally, Citigroup raised their price objective on shares of Clorox from $165.00 to $170.00 and gave the stock a "neutral" rating in a research report on Friday, September 6th. Five analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $155.00.

Clorox Stock Performance

Shares of Clorox stock traded up $0.02 during trading hours on Friday, reaching $167.17. The company had a trading volume of 465,385 shares, compared to its average volume of 1,220,052. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The Clorox Company has a one year low of $127.60 and a one year high of $171.35. The firm has a market cap of $20.69 billion, a PE ratio of 58.25, a price-to-earnings-growth ratio of 3.09 and a beta of 0.41. The business has a fifty day simple moving average of $163.09 and a 200 day simple moving average of $149.39.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating analysts' consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business's revenue for the quarter was up 27.0% on a year-over-year basis. During the same period in the previous year, the business earned $0.49 EPS. On average, analysts anticipate that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be issued a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 annualized dividend and a dividend yield of 2.92%. Clorox's dividend payout ratio is currently 170.04%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.